JDRF-CIHR Partnership to Defeat Diabetes
The JDRF-CIHR Partnership to Defeat Diabetes is a landmark collaboration between the Government of Canada, through CIHR, who invested $15M and JDRF Canada who matched that investment with an additional $15M to support transformative type 1 diabetes (T1D) research.
This unique partnership ensures that T1D remains a priority in Canadian health research and is based on a shared vision of improved care, treatment, outcomes and cures for those living with T1D.
Since its inception in 2017, this partnership has funded several innovative clinical trials and translational research projects with a view of accelerating the development of novel treatment approaches for people with T1D, in addition to cures for the disease. Multiple new cutting-edge projects will be funded in the coming year, promising to further accelerate JDRF’s mission. Learn more about the funded research projects from this partnership.
In the 2021 federal pre-budget submission, JDRF’s key recommendation was: The Government of Canada should honour the centenary of the discovery of insulin through a renewed research investment of $15M in the JDRF-CIHR Partnership to Diabetes to be matched by JDRF and its partners.
This is an example of an instrumental partnership that is able to leverage funds from multiple sources and increase the speed at which novel research is conducted – all with one ultimate goal in mind – turning type 1 into type none.